See More

Software issue casts doubt over some drugs

Oct 13 2014 19:54

The reliability of clinical tests used to win approval for some medicines could be in doubt due to an apparent software glitch.


US approves pricey new pill against hepatitis C

Oct 12 2014 16:45

US regulators have approved a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments, but that carries a steep price tag.


Aspen, GSK team up to extend foothold in Japan

Oct 09 2014 13:24

South Africa's Aspen Pharmacare has teamed up with shareholder GlaxoSmithKline to extend its foothold in Japan, a lucrative market for low-cost medicines.


'Animal pharm' catches Wall Street's attention

Oct 08 2014 21:07

Cancer drugs for cats, pain relief for dogs, diarrhoea drugs for hogs and hormones for dairy cattle: animal health is rapidly attracting Wall Street investors.


UK cost agency rejects GW's cannabis drug

Oct 08 2014 11:32

A pioneering cannabis drug developed by British firm GW Pharmaceuticals for treating spasticity in multiple sclerosis has been rejected as not cost-effective.


EU clears Novartis plan to sell animal health

Oct 03 2014 14:00

EU regulators have cleared the proposed sale of the animal health business of Swiss pharmaceutical giant Novartis to US group Eli Lilly.


Deal between Sanlam and AfroCentric

Sep 30 2014 17:35

Afrocentric Investment Corporation and Sanlam have reached agreements for the issue to Sanlam of an interest in AfroCentric’s wholly-owned subsidiary.


French pharmacists resist competition

Sep 30 2014 18:37

All but a handful of France's pharmacies have been closed on to protest the Socialist government's plans to introduce more competition into the sector.


Litha Healthcare increases revenue

Sep 26 2014 11:45

Unaudited condensed consolidated results for Litha Healthcare Group for the six months to June 30 show revenue has lifted, compared to the first half of 2013.


Big task awaits GSK's new chair

Sep 25 2014 14:17

The key task of GlaxoSmithKline's new chairperson Philip Hampton will be to help steer the drugmaker back to sustainable growth.

Inside Fin24.com


GSK to name RBS's Hampton as new chair

Sep 25 2014 10:30

Drugmaker GlaxoSmithKline will name Philip Hampton, who currently chairs Royal Bank of Scotland, as its next chair, says a person close to the process.


Jill Watts appointed GHG CEO

Sep 23 2014 18:55

Jill Watts has been appointed the CEO of General Healthcare Group and will assume her role on November 17, the company says.

We're talking about:

Small Business

Retailers of any shape and size can now unlock the power of mobile transacting.

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

The Post Office is on the brink of collapse This shows:

Previous results · Suggest a vote